nodes	percent_of_prediction	percent_of_DWPC	metapath
Suramin—F2—vertebral column—osteoporosis	0.0184	0.41	CbGeAlD
Suramin—PLA2G4A—Estradiol—Estropipate—osteoporosis	0.00956	0.417	CbGdCrCtD
Suramin—PLA2G4A—Estradiol—Conjugated Estrogens—osteoporosis	0.00725	0.316	CbGdCrCtD
Suramin—PLA2G4A—Estradiol—Ethinyl Estradiol—osteoporosis	0.00609	0.266	CbGdCrCtD
Suramin—SIRT1—uterus—osteoporosis	0.00573	0.128	CbGeAlD
Suramin—P2RX4—bone marrow—osteoporosis	0.00555	0.124	CbGeAlD
Suramin—RYR1—uterus—osteoporosis	0.0053	0.118	CbGeAlD
Suramin—SIRT1—bone marrow—osteoporosis	0.00486	0.109	CbGeAlD
Suramin—F2—bone marrow—osteoporosis	0.00257	0.0575	CbGeAlD
Suramin—PLA2G4A—bone marrow—osteoporosis	0.00237	0.0529	CbGeAlD
Suramin—FSHR—Signaling Pathways—WNT1—osteoporosis	0.000778	0.000835	CbGpPWpGaD
Suramin—F2—Folate Metabolism—TNF—osteoporosis	0.000777	0.000834	CbGpPWpGaD
Suramin—ARSA—Metabolism of lipids and lipoproteins—POMC—osteoporosis	0.000776	0.000832	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—ADCY5—osteoporosis	0.000773	0.000829	CbGpPWpGaD
Suramin—F2—Vitamin B12 Metabolism—IL6—osteoporosis	0.000771	0.000827	CbGpPWpGaD
Suramin—PLA2G2A—Spinal Cord Injury—IL6—osteoporosis	0.000765	0.00082	CbGpPWpGaD
Suramin—F2—GPCR ligand binding—WNT1—osteoporosis	0.00076	0.000815	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—FGA—osteoporosis	0.000757	0.000812	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—IDH2—osteoporosis	0.00075	0.000805	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	0.000746	0.0008	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—ADCY5—osteoporosis	0.000746	0.0008	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—PTH1R—osteoporosis	0.000741	0.000794	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—CALCR—osteoporosis	0.000741	0.000794	CbGpPWpGaD
Suramin—SIRT1—Gene Expression—ESR2—osteoporosis	0.00073	0.000783	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—PTHLH—osteoporosis	0.000729	0.000782	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—BMP2—osteoporosis	0.000729	0.000782	CbGpPWpGaD
Suramin—F2—Hemostasis—RAP1A—osteoporosis	0.000729	0.000781	CbGpPWpGaD
Suramin—ARSA—Metabolism—ENO1—osteoporosis	0.000719	0.000771	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—FGB—osteoporosis	0.000713	0.000765	CbGpPWpGaD
Suramin—ARSA—Metabolism—PSMA2—osteoporosis	0.000709	0.00076	CbGpPWpGaD
Suramin—ARSA—Metabolism—PSMA5—osteoporosis	0.000709	0.00076	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—MGLL—osteoporosis	0.000708	0.00076	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—CYP27A1—osteoporosis	0.000705	0.000757	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—PTHLH—osteoporosis	0.000704	0.000755	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—BMP2—osteoporosis	0.000704	0.000755	CbGpPWpGaD
Suramin—SIRT1—Circadian rythm related genes—IL6—osteoporosis	0.000695	0.000746	CbGpPWpGaD
Suramin—F2—Metabolism of proteins—TLN1—osteoporosis	0.000695	0.000746	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—FGB—osteoporosis	0.000689	0.000739	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—PSMA2—osteoporosis	0.000688	0.000738	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—PSMA5—osteoporosis	0.000688	0.000738	CbGpPWpGaD
Suramin—F2—GPCR ligand binding—PTHLH—osteoporosis	0.000687	0.000737	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—ACP5—osteoporosis	0.000686	0.000736	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	0.000677	0.000727	CbGpPWpGaD
Suramin—ARSA—Metabolism of proteins—POMC—osteoporosis	0.00067	0.000719	CbGpPWpGaD
Suramin—F2—Metabolism of proteins—REN—osteoporosis	0.000668	0.000717	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—RAP1A—osteoporosis	0.000666	0.000715	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—PSMA5—osteoporosis	0.000665	0.000713	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—PSMA2—osteoporosis	0.000665	0.000713	CbGpPWpGaD
Suramin—F2—Hemostasis—FGA—osteoporosis	0.000661	0.000709	CbGpPWpGaD
Suramin—ARSA—Metabolism of proteins—IGF1—osteoporosis	0.000645	0.000692	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—MGLL—osteoporosis	0.000643	0.00069	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—CALCA—osteoporosis	0.000642	0.000688	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—TPI1—osteoporosis	0.000638	0.000684	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	0.000635	0.000681	CbGpPWpGaD
Suramin—F2—Folate Metabolism—IL6—osteoporosis	0.000627	0.000673	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	0.000627	0.000673	CbGpPWpGaD
Suramin—P2RY2—GPCR downstream signaling—POMC—osteoporosis	0.000626	0.000671	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—CALCA—osteoporosis	0.00062	0.000665	CbGpPWpGaD
Suramin—F2—Peptide ligand-binding receptors—POMC—osteoporosis	0.000619	0.000664	CbGpPWpGaD
Suramin—F2—Selenium Micronutrient Network—TNF—osteoporosis	0.000617	0.000662	CbGpPWpGaD
Suramin—F2—GPCR ligand binding—CALCA—osteoporosis	0.000605	0.000649	CbGpPWpGaD
Suramin—FSHR—GPCR downstream signaling—POMC—osteoporosis	0.000604	0.000648	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—FGA—osteoporosis	0.000604	0.000648	CbGpPWpGaD
Suramin—F2—Hemostasis—FGB—osteoporosis	0.000601	0.000645	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—P4HB—osteoporosis	0.0006	0.000643	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—GAPDH—osteoporosis	0.000589	0.000631	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—MGLL—osteoporosis	0.000588	0.000631	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—KL—osteoporosis	0.000583	0.000625	CbGpPWpGaD
Suramin—SIRT1—Gene Expression—VDR—osteoporosis	0.00058	0.000622	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—FDPS—osteoporosis	0.000579	0.000621	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—PKM—osteoporosis	0.000579	0.000621	CbGpPWpGaD
Suramin—ARSA—Metabolism—CYP19A1—osteoporosis	0.000575	0.000617	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—RAP1A—osteoporosis	0.000573	0.000615	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—POMC—osteoporosis	0.000568	0.000609	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—KL—osteoporosis	0.000563	0.000603	CbGpPWpGaD
Suramin—SIRT1—Cellular responses to stress—IL6—osteoporosis	0.000559	0.0006	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—IL6R—osteoporosis	0.000554	0.000595	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—FGB—osteoporosis	0.00055	0.00059	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—POMC—osteoporosis	0.000549	0.000589	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—GPD2—osteoporosis	0.000549	0.000588	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—PGLS—osteoporosis	0.000549	0.000588	CbGpPWpGaD
Suramin—F2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6R—osteoporosis	0.000547	0.000587	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	0.000543	0.000582	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—IL6R—osteoporosis	0.000535	0.000574	CbGpPWpGaD
Suramin—F2—Signaling Pathways—SOST—osteoporosis	0.000529	0.000567	CbGpPWpGaD
Suramin—F2—Platelet activation, signaling and aggregation—IGF1—osteoporosis	0.000528	0.000566	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—PNP—osteoporosis	0.000502	0.000538	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—ATIC—osteoporosis	0.000502	0.000538	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism of lipids and lipoproteins—POMC—osteoporosis	0.0005	0.000536	CbGpPWpGaD
Suramin—F2—Selenium Micronutrient Network—IL6—osteoporosis	0.000498	0.000534	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—SOST—osteoporosis	0.000484	0.000519	CbGpPWpGaD
Suramin—PLA2G4A—Platelet activation, signaling and aggregation—IGF1—osteoporosis	0.000483	0.000518	CbGpPWpGaD
Suramin—F2—Signaling Pathways—CALCR—osteoporosis	0.000478	0.000513	CbGpPWpGaD
Suramin—F2—Signaling Pathways—PTH1R—osteoporosis	0.000478	0.000513	CbGpPWpGaD
Suramin—ARSA—Metabolism—ADCY5—osteoporosis	0.00047	0.000504	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—PTH—osteoporosis	0.000468	0.000502	CbGpPWpGaD
Suramin—ARSA—Metabolism—GPX1—osteoporosis	0.000468	0.000502	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—ENO1—osteoporosis	0.000463	0.000497	CbGpPWpGaD
Suramin—PLA2G4A—PDGFR-beta signaling pathway—MYC—osteoporosis	0.000458	0.000491	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—PSMA5—osteoporosis	0.000457	0.00049	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—PSMA2—osteoporosis	0.000457	0.00049	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—CNR2—osteoporosis	0.000457	0.00049	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—ADCY5—osteoporosis	0.000456	0.000489	CbGpPWpGaD
Suramin—SIRT1—Gene Expression—ESR1—osteoporosis	0.000443	0.000475	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—SPP1—osteoporosis	0.000442	0.000474	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—ADCY5—osteoporosis	0.000441	0.000473	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—PTH1R—osteoporosis	0.000438	0.000469	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—CALCR—osteoporosis	0.000438	0.000469	CbGpPWpGaD
Suramin—ARSA—Metabolism—MTHFR—osteoporosis	0.000432	0.000463	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—OXCT1—osteoporosis	0.000427	0.000458	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—CA2—osteoporosis	0.000427	0.000458	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—SPP1—osteoporosis	0.000426	0.000457	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—PTH—osteoporosis	0.000425	0.000456	CbGpPWpGaD
Suramin—F2—Metabolism of proteins—ACE—osteoporosis	0.000417	0.000447	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—MGLL—osteoporosis	0.000416	0.000446	CbGpPWpGaD
Suramin—F2—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	0.000416	0.000446	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—CNR2—osteoporosis	0.000415	0.000445	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—IRS2—osteoporosis	0.000399	0.000428	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	0.000392	0.00042	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—LEP—osteoporosis	0.000391	0.000419	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—WNT1—osteoporosis	0.00039	0.000418	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—PTH—osteoporosis	0.000389	0.000417	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—PTHLH—osteoporosis	0.000388	0.000416	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—IRS2—osteoporosis	0.000386	0.000414	CbGpPWpGaD
Suramin—F2—Signaling Pathways—MGLL—osteoporosis	0.00038	0.000408	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—CNR2—osteoporosis	0.000379	0.000407	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—LEP—osteoporosis	0.000377	0.000405	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—ESR1—osteoporosis	0.000373	0.0004	CbGpPWpGaD
Suramin—F2—Signaling Pathways—LRP5—osteoporosis	0.000371	0.000398	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—CYP19A1—osteoporosis	0.000371	0.000397	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—ESR1—osteoporosis	0.00036	0.000386	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—WNT1—osteoporosis	0.000357	0.000382	CbGpPWpGaD
Suramin—F2—Signaling Pathways—LRP6—osteoporosis	0.000355	0.000381	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—IDH2—osteoporosis	0.000353	0.000379	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—PTHLH—osteoporosis	0.000353	0.000378	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—IRS1—osteoporosis	0.000349	0.000374	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—MGLL—osteoporosis	0.000348	0.000373	CbGpPWpGaD
Suramin—ARSA—Metabolism—POMC—osteoporosis	0.000346	0.000371	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—CALCA—osteoporosis	0.000342	0.000367	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—LRP5—osteoporosis	0.000339	0.000364	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—IRS1—osteoporosis	0.000337	0.000361	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—POMC—osteoporosis	0.000336	0.00036	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—CYP27A1—osteoporosis	0.000332	0.000356	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—IL6R—osteoporosis	0.000327	0.000351	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	0.000326	0.00035	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	0.000325	0.000349	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—LRP6—osteoporosis	0.000325	0.000348	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—POMC—osteoporosis	0.000324	0.000348	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—ACP5—osteoporosis	0.000323	0.000347	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—IGF1—osteoporosis	0.000323	0.000346	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—PTHLH—osteoporosis	0.000322	0.000346	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	0.000319	0.000342	CbGpPWpGaD
Suramin—F2—Platelet activation, signaling and aggregation—TGFB1—osteoporosis	0.000317	0.000339	CbGpPWpGaD
Suramin—F2—GPCR ligand binding—POMC—osteoporosis	0.000316	0.000339	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—IL6R—osteoporosis	0.000316	0.000339	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—IGF1—osteoporosis	0.000312	0.000334	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—CALCA—osteoporosis	0.00031	0.000333	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	0.000304	0.000326	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—ADCY5—osteoporosis	0.000303	0.000325	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—GPX1—osteoporosis	0.000302	0.000324	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—TPI1—osteoporosis	0.000301	0.000322	CbGpPWpGaD
Suramin—F2—Signaling Pathways—TLN1—osteoporosis	0.0003	0.000321	CbGpPWpGaD
Suramin—PLA2G4A—Platelet activation, signaling and aggregation—TGFB1—osteoporosis	0.00029	0.000311	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—CALCA—osteoporosis	0.000284	0.000304	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—P4HB—osteoporosis	0.000283	0.000303	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—MTHFR—osteoporosis	0.000278	0.000299	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—GAPDH—osteoporosis	0.000277	0.000297	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—TLN1—osteoporosis	0.000274	0.000294	CbGpPWpGaD
Suramin—F2—Hemostasis—IGF1—osteoporosis	0.000272	0.000292	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—RAP1A—osteoporosis	0.00027	0.00029	CbGpPWpGaD
Suramin—F2—Metabolism of proteins—LEP—osteoporosis	0.000259	0.000278	CbGpPWpGaD
Suramin—F2—Signaling Pathways—P4HB—osteoporosis	0.000258	0.000277	CbGpPWpGaD
Suramin—F2—Signaling Pathways—PTH—osteoporosis	0.000251	0.00027	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—IGF1—osteoporosis	0.000249	0.000267	CbGpPWpGaD
Suramin—F2—Signaling Pathways—RAP1A—osteoporosis	0.000247	0.000265	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—IL6—osteoporosis	0.000247	0.000265	CbGpPWpGaD
Suramin—F2—Signaling Pathways—CNR2—osteoporosis	0.000245	0.000263	CbGpPWpGaD
Suramin—F2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	0.000244	0.000262	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—ADCY5—osteoporosis	0.000243	0.000261	CbGpPWpGaD
Suramin—F2—Signaling Pathways—NFATC1—osteoporosis	0.000241	0.000258	CbGpPWpGaD
Suramin—F2—Signaling Pathways—DKK1—osteoporosis	0.000239	0.000256	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—IL6—osteoporosis	0.000238	0.000256	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—P4HB—osteoporosis	0.000236	0.000253	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism of lipids and lipoproteins—POMC—osteoporosis	0.000236	0.000253	CbGpPWpGaD
Suramin—SIRT1—Gene Expression—MYC—osteoporosis	0.00023	0.000247	CbGpPWpGaD
Suramin—F2—Signaling Pathways—WNT1—osteoporosis	0.00023	0.000247	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—PTH—osteoporosis	0.00023	0.000247	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—RAP1A—osteoporosis	0.000226	0.000242	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—CNR2—osteoporosis	0.000224	0.00024	CbGpPWpGaD
Suramin—F2—Signaling Pathways—FGA—osteoporosis	0.000224	0.00024	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—POMC—osteoporosis	0.000223	0.000239	CbGpPWpGaD
Suramin—F2—Metabolism of proteins—POMC—osteoporosis	0.000223	0.000239	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—ADCY5—osteoporosis	0.000221	0.000237	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—NFATC1—osteoporosis	0.00022	0.000236	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—DKK1—osteoporosis	0.000219	0.000234	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—ENO1—osteoporosis	0.000218	0.000234	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—PSMA5—osteoporosis	0.000215	0.000231	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—PSMA2—osteoporosis	0.000215	0.000231	CbGpPWpGaD
Suramin—F2—Metabolism of proteins—IGF1—osteoporosis	0.000214	0.00023	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—WNT1—osteoporosis	0.000211	0.000226	CbGpPWpGaD
Suramin—F2—Signaling Pathways—PTHLH—osteoporosis	0.000208	0.000223	CbGpPWpGaD
Suramin—F2—Signaling Pathways—BMP2—osteoporosis	0.000208	0.000223	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—FGA—osteoporosis	0.000205	0.00022	CbGpPWpGaD
Suramin—F2—Signaling Pathways—FGB—osteoporosis	0.000204	0.000219	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—ADCY5—osteoporosis	0.000202	0.000217	CbGpPWpGaD
Suramin—F2—Signaling Pathways—PSMA2—osteoporosis	0.000197	0.000211	CbGpPWpGaD
Suramin—F2—Signaling Pathways—PSMA5—osteoporosis	0.000197	0.000211	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—MYC—osteoporosis	0.000194	0.000208	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—TGFB1—osteoporosis	0.000194	0.000208	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—PTHLH—osteoporosis	0.00019	0.000204	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—BMP2—osteoporosis	0.00019	0.000204	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—MYC—osteoporosis	0.000187	0.000201	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—TGFB1—osteoporosis	0.000187	0.000201	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—FGB—osteoporosis	0.000186	0.0002	CbGpPWpGaD
Suramin—F2—Signaling Pathways—CALCA—osteoporosis	0.000183	0.000197	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—PSMA2—osteoporosis	0.00018	0.000193	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—PSMA5—osteoporosis	0.00018	0.000193	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—POMC—osteoporosis	0.000179	0.000192	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—CYP19A1—osteoporosis	0.000175	0.000187	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—CALCA—osteoporosis	0.000168	0.00018	CbGpPWpGaD
Suramin—F2—Signaling Pathways—KL—osteoporosis	0.000166	0.000179	CbGpPWpGaD
Suramin—F2—Hemostasis—TGFB1—osteoporosis	0.000163	0.000175	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—POMC—osteoporosis	0.000162	0.000174	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—IL6R—osteoporosis	0.000158	0.00017	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—KL—osteoporosis	0.000152	0.000163	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—TGFB1—osteoporosis	0.000149	0.00016	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—POMC—osteoporosis	0.000149	0.000159	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—IL6—osteoporosis	0.000146	0.000156	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—IL6R—osteoporosis	0.000145	0.000155	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—ADCY5—osteoporosis	0.000143	0.000153	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—GPX1—osteoporosis	0.000142	0.000152	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—IL6—osteoporosis	0.000141	0.000151	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—MTHFR—osteoporosis	0.000131	0.000141	CbGpPWpGaD
Suramin—F2—Signaling Pathways—ADCY5—osteoporosis	0.00013	0.00014	CbGpPWpGaD
Suramin—F2—Signaling Pathways—SPP1—osteoporosis	0.000126	0.000135	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—ADCY5—osteoporosis	0.000119	0.000128	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—SPP1—osteoporosis	0.000115	0.000124	CbGpPWpGaD
Suramin—F2—Signaling Pathways—IRS2—osteoporosis	0.000114	0.000122	CbGpPWpGaD
Suramin—F2—Signaling Pathways—LEP—osteoporosis	0.000112	0.00012	CbGpPWpGaD
Suramin—F2—Signaling Pathways—ESR1—osteoporosis	0.000107	0.000114	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—POMC—osteoporosis	0.000105	0.000113	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—IRS2—osteoporosis	0.000104	0.000112	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—LEP—osteoporosis	0.000102	0.00011	CbGpPWpGaD
Suramin—F2—Signaling Pathways—IRS1—osteoporosis	9.96e-05	0.000107	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—ESR1—osteoporosis	9.75e-05	0.000105	CbGpPWpGaD
Suramin—F2—Signaling Pathways—POMC—osteoporosis	9.59e-05	0.000103	CbGpPWpGaD
Suramin—F2—Signaling Pathways—IL6R—osteoporosis	9.36e-05	0.0001	CbGpPWpGaD
Suramin—F2—Signaling Pathways—IGF1—osteoporosis	9.23e-05	9.9e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—IRS1—osteoporosis	9.11e-05	9.77e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—POMC—osteoporosis	8.77e-05	9.41e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—IL6R—osteoporosis	8.56e-05	9.18e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—IGF1—osteoporosis	8.44e-05	9.05e-05	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—IL6—osteoporosis	7.06e-05	7.57e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—IL6—osteoporosis	6.45e-05	6.92e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—MYC—osteoporosis	5.54e-05	5.95e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—TGFB1—osteoporosis	5.53e-05	5.93e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—MYC—osteoporosis	5.07e-05	5.44e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—TGFB1—osteoporosis	5.06e-05	5.43e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—IL6—osteoporosis	4.17e-05	4.47e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—IL6—osteoporosis	3.81e-05	4.09e-05	CbGpPWpGaD
